Results 251 to 260 of about 37,143 (281)
Some of the next articles are maybe not open access.

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

[Antiphospholipid antibodies].

Rinsho byori. The Japanese journal of clinical pathology, 2003
The concept of antiphospholipid syndrome(APS) has been widely accepted. Antiphospholipid antibodies originally included anticardiolipin antibodies and lupus anticoagulants as serological marker of APS. However, recent advances have shown that most pathogenic antiphospholipid antibodies are directed to phospholipid binding proteins such as beta 2 ...
Junichi, Kaburaki   +2 more
openaire   +1 more source

IgA Antiphospholipid Antibodies

Thrombosis and Haemostasis, 1999
L B, Keil, H, Eguchi, V A, DeBari
openaire   +2 more sources

[Antiphospholipid antibodies].

Annales de biologie clinique, 1995
The term 'antiphospholipids' (APL) refers to heterogeneous auto-antibodies, including anticardiolipins detected by immunological methods and lupus anticoagulants detected by clotting tests. APL are currently of considerable interest, both from a clinical and a biological point of view, since their presence is associated with thromboembolic events.
B, Boutière, D, Arnoux, J, Sampol
openaire   +1 more source

ANTIPHOSPHOLIPID ANTIBODIES

British Journal of Haematology, 1990
openaire   +2 more sources

ANTIPHOSPHOLIPID ANTIBODIES

Immunology and Allergy Clinics of North America, 1994
J. Bruce Smith, F. Susan Cowchock
  +4 more sources

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera   +2 more
exaly  

Home - About - Disclaimer - Privacy